The Food and Drug Administration (FDA), through its Center for Biologics Evaluation and Research (CBER) convened a high-level roundtable on cell and gene therapy (CGT), bringing together leading scientists, clinicians, federal officials, and patient advocates. Moderated by CBER Director Dr. Vinay Prasad, the session featured prominent experts including Dr. Catherine Bollard, Dr. Crystal Mackall, Dr. Fyodor Urnov, and Dr. Michelle… (Colocho, June 5, 2025) #Costs, #Drug Pricing, #Food and Drug Administration, #National Institutes of Health, #Pediatrics, #Therapy